Eric G. Carter - 21 Jul 2023 Form 3 Insider Report for AEON Biopharma, Inc. (AEON)

Role: Director
Signature: /s/ Alexander Wilson, Attorney-in-Fact
Issuer symbol: AEON
Transactions as of: 21 Jul 2023
Transactions value $: $0
Form type: 3
Filing time: 24 Jul 2023, 21:02:04 UTC
Next filing: 16 Aug 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.